助手标题  
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
   晚期非小细胞肺癌临床 的翻译结果: 查询用时:0.434秒
图标索引 在分类学科中查询
所有学科
肿瘤学
更多类别查询

图标索引 历史查询
 

晚期非小细胞肺癌临床
相关语句
  advanced non-small cell lung cancer
     Study on TCM Comprehensive Therapy in the Treatment of Advanced Non-small Cell Lung Cancer
     中医综合疗法治疗晚期非小细胞肺癌临床研究
短句来源
     Clinical analysis of paclitaxel combined with carboplatin in the treatment of advanced non-small cell lung cancer
     紫杉醇联合卡铂治疗晚期非小细胞肺癌临床分析
短句来源
     Clinical observation of hyperthermia combined with chemotherapy in the treatment of advanced non-small cell lung cancer
     热疗联合化疗治疗晚期非小细胞肺癌临床观察
短句来源
     Objective To observe the clinical effects of using gemcitabine (GEM) combined with cisplatin (DDP) in treating advanced non-small cell lung cancer and its side effects.
     目的观察健择(GEM)加顺铂(DDP)联合治疗晚期非小细胞肺癌,临床疗效及毒副反应。
短句来源
     Clinical observation of paclitaxel and pirarubicin combined with cisplatin in treatment of 52 cases of advanced non-small cell lung cancer
     紫杉醇、吡柔比星和顺铂治疗52例晚期非小细胞肺癌临床观察
短句来源
更多       
  “晚期非小细胞肺癌临床”译为未确定词的双语例句
     Clinical observation of NP and CAP in the treatment of advanced non small cell lung cancer
     NP与CAP方案治疗晚期非小细胞肺癌临床观察
短句来源
     Clinical Observation of Late Nonsmall-cell Lung Cancer Treated by Chemotherapy Combined with Yanshu Injection
     岩舒注射液联合化疗治疗晚期非小细胞肺癌临床观察
短句来源
     Clinical evaluation of NP and GP in treatment of patiens with non-small cell lung cancer
     NP与GP方案治疗晚期非小细胞肺癌临床评价
短句来源
     Clinical study of combination chemotherapy with gemcitabine and cisplatin in the treatment of advanced non-small-cell lung cancer
     吉西他滨联合顺铂治疗晚期非小细胞肺癌临床研究
短句来源
     Clinical observation on advanced non-small cell carcinoma of lung treated by Xiaoyan decoction
     消岩汤剂治疗晚期非小细胞肺癌临床研究
短句来源
更多       
  相似匹配句对
     Gemcitabine in the treatment of advanced nonsmallcell lung cancer
     Gemcitabine治疗晚期小细胞肺癌临床研究
短句来源
     The Effect of Vinorelbine plus Cisplatin in the Treatment of Advanced Non-small Cell Lung Cancer
     NP方案治疗晚期小细胞肺癌临床观察
短句来源
     Clinical Observation of Chemotherapy and Chinese Medicine in Treating Advanced Non-small Cell Lung Cancer
     中西药综合治疗晚期小细胞肺癌临床观察
短句来源
     Treatment of advanced non-small cell lung cancer with IP regimen
     TI方案治疗晚期小细胞肺癌临床观察
短句来源
     Clinical research of cisplatin-mitomycin-navelbline for advanced non-small cell cancer
     MNP方案治疗晚期小细胞肺癌临床研究
短句来源
查询“晚期非小细胞肺癌临床”译词为用户自定义的双语例句

    我想查看译文中含有:的双语例句
例句
为了更好的帮助您理解掌握查询词或其译词在地道英语中的实际用法,我们为您准备了出自英文原文的大量英语例句,供您参考。
  advanced non-small cell lung cancer
Local failure is the one of the most frequent cause of tumor related death in locally advanced non-small cell lung cancer (LAD-NSCLC).
      
Three-Times-Daily Radiotherapy with Induction Chemotherapy in Locally Advanced Non-Small Cell Lung Cancer
      
Paclitaxel plus cisplatin in the treatment of advanced non-small cell lung cancer
      
Clinical efficacy of vinorelbine plus cisplatin in advanced non-small cell lung cancer
      
Effect of neoadjuvant chemotherapy using paclitaxel combined with carboplatin on advanced non-small cell lung cancer
      
更多          


PURPOSE To study the effect and toxicity of different doses of paclitaxol in the treatment of advanced non small cell lung cancer (NSCLC). METHODS Patients of a group were given paclitaxel 105 mg/m 2(3 h) d 1,cisplatin 40 mg/m 2 (d 2~4) RESULTS There were no complete relief (CR) in the A and B group. 4 of 11 cases of A group reached partial relief (PR) (36.4%),3 of which were previously untreated cases (3/5,60%).1 of 6 was a previously treated case (17%).4 of 14 case of B group reached PR(28.6%),2...

PURPOSE To study the effect and toxicity of different doses of paclitaxol in the treatment of advanced non small cell lung cancer (NSCLC). METHODS Patients of a group were given paclitaxel 105 mg/m 2(3 h) d 1,cisplatin 40 mg/m 2 (d 2~4) RESULTS There were no complete relief (CR) in the A and B group. 4 of 11 cases of A group reached partial relief (PR) (36.4%),3 of which were previously untreated cases (3/5,60%).1 of 6 was a previously treated case (17%).4 of 14 case of B group reached PR(28.6%),2 of 5 of which were previously untreated cases (40%),2 of 9 of were previously treated cases (22%).Leukopenia and peripheral neuropathy of A group were less than B group,other toxicities were similar. CONCLUSIONS Two doses of paclitaxol plus cisplatinare are effective for previously untreated advanced NSCLC,but less effective for previously treated cases especially with a dose of 105 mg/m 2.

目的研究不同剂量的紫杉醇联合固定剂量的顺铂治疗晚期非小细胞肺癌的临床疗效和不良反应。方法第1天甲组用紫杉醇105mg/m2,乙组用紫杉醇180mg/m2,两组第2~5天均用顺铂40mg/m2。应用紫杉醇前予抗过敏治疗,紫杉醇均用3h的静脉滴注。结果两组均无完全缓解(CR)。甲组部分缓解(PR)364%(4/11),初治病人为60%(3/5),复治为17%(1/6)。乙组PR286%(4/14),初治为40%(2/5),复治22%(2/9)。中性粒细胞的抑制作用甲组轻于乙组,周围神经毒性亦低于乙组。其余不良反应两组相似。结论两种剂量的紫杉醇联合固定剂量的顺铂对初治晚期非小细胞肺癌均有效,但对复治病例疗效差,特别是105mg/m2组。

Objective To compare the effect and toxicity of three different combined plan for advanced non small cell lung cancer(NSCLC).Methods The clnical data of 102 cases with advanced NSCLC treated with (1)Pingxiao capsule plus mitomycinc plus vindesine pins cisplatin(pmvp,34 cases),(2)mitomycin C plus vindesine plus cisplatin(mvp,33 cases),and (3)cyclophosphamide plus adriamycin plus cisplatin (CAP,35 cases)were analysed.Results The response rate was 52.9%(18/34)in patients treated with pmvp,39 4% (13/33)in those...

Objective To compare the effect and toxicity of three different combined plan for advanced non small cell lung cancer(NSCLC).Methods The clnical data of 102 cases with advanced NSCLC treated with (1)Pingxiao capsule plus mitomycinc plus vindesine pins cisplatin(pmvp,34 cases),(2)mitomycin C plus vindesine plus cisplatin(mvp,33 cases),and (3)cyclophosphamide plus adriamycin plus cisplatin (CAP,35 cases)were analysed.Results The response rate was 52.9%(18/34)in patients treated with pmvp,39 4% (13/33)in those treated with MVP,and 28.6%(10/35)in those with CAP.The difference of the effective rates between pmvp and CAP was significant( P <0 05) In the MVP group the CEA descending rate was 75%; in the MVP group the CEA descending rate was 75.1%; in the CAP group the CEA descending rate was 43.8% The diffrence of dlescending rats between PMVP and CAP groups was signicant( P <0 05) The side effect in the PMVP group was less and milder than in the MVP and CAP group,Couclusion These showed that Pingxiao capsucle combined with chemotherapy was a safe and effective method for treating NSCLC and deserved to be recommended

目的 比较三组不同联合方案对晚期非小细胞肺癌的疗效和毒性。方法 统计分析平消胶囊 (加丝裂霉素、长春酰胺、顺铂 )方案、MVP方案及CAP(环磷酰胺、阿霉素、顺铂 )方案治疗的 10 2例晚期非小细胞肺癌的临床资料。结果 平消胶囊加MVP组有效率为 5 2 9% (18/34) ,其中完全缓解 2例 ;MVP组有效率为 39 4% (13/33) ;CAP组有效率为 2 8 6 % (10 /35 )。平消胶囊加MVP组与CAP组差异有显著性。平消胶囊加MVP组癌胚抗原测定 (CEA)下降至正常以下为 75 % ;MVP组CEA下降至正常以下为 75 1% ;CAP组CEA下降至正常以下 43 8%。平消胶囊加MVP组与CAP组CEA下降至正常值以下差异有显著性 (P <0 0 5 )。毒副反应 :平消胶囊加MVP组较对照组明显少而轻。结论 平消胶囊联合化疗治疗肺癌安全有效 ,值得推广应用

Objective:To evaluate the efficacy and side effects of the combination of paclitaxel and cisplatin in the treatment of advanced non small cell lung cancer(NSCLC).Methods:Thirty four patients with stages Ⅲ and Ⅳ of NSCLC were treated with the combination for two courses.Each courses lasted for 3 weeks.In each week,paclitaxel was administered on day 1 at a dose of 150 mg/m 2 and cisplatin at a dose of 20 mg/m 2 from day 2 to day 6.Results:Eighteen...

Objective:To evaluate the efficacy and side effects of the combination of paclitaxel and cisplatin in the treatment of advanced non small cell lung cancer(NSCLC).Methods:Thirty four patients with stages Ⅲ and Ⅳ of NSCLC were treated with the combination for two courses.Each courses lasted for 3 weeks.In each week,paclitaxel was administered on day 1 at a dose of 150 mg/m 2 and cisplatin at a dose of 20 mg/m 2 from day 2 to day 6.Results:Eighteen patients achieved partial response.The overall response rate was 56 5%.The main side effect were myelosuppresive toxicities,gastrointestinal disturbance,alopecia,myalgia and arthralgia.Conclusion:The combination of paclitaxel and cisplatin is effective and well tolerated in the treatment of advanced NSCLC.

目的 :评价紫杉醇联合顺铂化疗治疗晚期非小细胞肺癌的临床疗效和不良反应。方法 :34例晚期非小细胞肺癌患者d 1采用紫杉醇 1 50mg/m2 ,d 2~d 6使用顺铂 2 0mg/m2 。 3周为 1个周期 ,均治疗 2个周期。结果 :34例晚期非小细胞肺癌中 ,部分缓解 1 8例、稳定 9例、恶化 7例 ,总有效率 56 5%。初治者有效率为 57 7% (1 5/2 6) ,复治者有效率为 37 5%(3/8)。主要毒副反应为骨髓抑制、胃肠道反应、脱发、肌肉及关节疼痛。结论 :紫杉醇联合顺铂治疗非小细胞肺癌具有较好的疗效 ,毒副作用可以耐受

 
<< 更多相关文摘    
图标索引 相关查询

 


 
CNKI小工具
在英文学术搜索中查有关晚期非小细胞肺癌临床的内容
在知识搜索中查有关晚期非小细胞肺癌临床的内容
在数字搜索中查有关晚期非小细胞肺癌临床的内容
在概念知识元中查有关晚期非小细胞肺癌临床的内容
在学术趋势中查有关晚期非小细胞肺癌临床的内容
 
 

CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社